Ben Mullish

Ben Mullish has elucidated the role of microbiome-mediated bile acid metabolism in modulating cancer immunity, demonstrating that specific bacterial bile acid transformations influence regulatory T cell differentiation and anti-tumor immune responses. His work on defined microbial consortia as alternatives to FMT has advanced the development of standardized, reproducible microbiome therapeutics for oncology. His research on microbiome-mediated drug metabolism has revealed how gut bacteria alter the pharmacokinetics and efficacy of cancer drugs.